Early responses of the STAT3 pathway to platinum drugs are associated with cisplatin resistance in epithelial ovarian cancer

Brazilian Journal of Medical and Biological Research; Sheng, W.J.; Jiang, H.; Wu, D.L.; Zheng, J.H..
Braz. j. med. biol. res ; 46(8): 650-658, ago. 2013. graf
Artículo en Inglés | LILACS | ID: lil-684524

Documentos relacionados

  1. Hallmarks of response, resistance, and toxicity to immune checkpoint blockade.
  2. Colorectal Cancer Cells Enter a Diapause-like DTP State to Survive Chemotherapy.
  3. Endocytosis Inhibition in Humans to Improve Responses to ADCC-Mediating Antibodies.
  4. ERα is an RNA-binding protein sustaining tumor cell survival and drug resistance.
  5. F-Box Protein-Mediated Resistance to PARP Inhibitor Therapy.
  6. Diverse clonal fates emerge upon drug treatment of homogeneous cancer cells.
  7. RHOJ controls EMT-associated resistance to chemotherapy.
  8. Targeted chemotherapy overcomes drug resistance in melanoma.
  9. Toward Minimal Residual Disease-Directed Therapy in Melanoma.
  10. Tunicamycin-induced endoplasmic reticulum stress inhibits chemoresistance of FaDu hypopharyngeal carcinoma cells in 3D collagen I cultures and in vivo.